3-[1-(4-Fluorophenyl)-2-oxopiperidin-3-yl]-3-oxopropanenitrile

Catalog No.: 
ACAEGN970
CAS No.: 
2060025-17-2
Molecular Formula: 
C14H13FN2O2
Molecular Weight: 
260.27
3-[1-(4-Fluorophenyl)-2-oxopiperidin-3-yl]-3-oxopropanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$169.00InquiryInquiry
1g95%$511.00InquiryInquiry
5g95%$2529.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[1-(4-Fluorophenyl)-2-oxopiperidin-3-yl]-3-oxopropanenitrile
IUPAC Name3-(1-(4-fluorophenyl)-2-oxopiperidin-3-yl)-3-oxopropanenitrile
MDL No.MFCD30487589
Molecular FormulaC14H13FN2O2
Molecular Weight260.27
SMILESN#CCC(C1C(N(C2=CC=C(F)C=C2)CCC1)=O)=O
InChI KeyQJFXFVVSZPZDTJ-UHFFFAOYSA-N
Synonym3-Piperidinepropanenitrile, 1-(4-fluorophenyl)-β,2-dioxo-
CAS No.2060025-17-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACAEGN970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLXJY256 route compound structure diagram
    ACLXJY256352-34-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEGN970 route product structure diagram
    ACAEGN9702060025-17-2
Inquiry

2. ACAEGN970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEGN970 route product structure diagram
    ACAEGN9702060025-17-2
Inquiry

3. ACAEGN970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAEGN970 route product structure diagram
    ACAEGN9702060025-17-2
Inquiry

Comments (0)